ArticleEJNMMI research2025

Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia.

Moritz B Bastian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.